MedTrace Logo

Individually Targeted Neuromodulation for Contamination-based OCD

NCT05048251 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-03-15

No results posted yet for this study

Summary

Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size fits all" approach and are used for all patients regardless of symptom type. In this project, the investigators propose to investigate whether a novel method of transcranial magnetic stimulation specifically reduces contamination/washing symptoms - one of the most common types of OCD.

Conditions

  • Obsessive-Compulsive Disorder

Interventions

DEVICE

cTBS

continuous theta burst stimulation

DEVICE

iTBS

intermittent theta burst stimulation

DEVICE

sham

sham stimulation

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Brian P Brennan, MD · Mclean Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-06-30
Completion
2024-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05048251 on ClinicalTrials.gov